A
$ Value
$12K
Shares
191
Price
$65
Filed
Apr 15
Insider
Name
Kaye Edward M. MD
Title
—
CIK
0001522780
Roles
Director
Transaction Details
Transaction Date
2026-04-15
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,365
Footnotes
Shares of common stock granted pursuant to Director Equity in Lieu of Cash Retainer Program. Shares are fully vested.
Filing Info
Kaye Edward M. MD's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | CYTK | A | $12K |
| 2025-07-15 | CYTK | A | $12K |
| 2025-06-10 | RNA | A | $0 |
| 2025-06-10 | RNA | A | $0 |
| 2025-06-05 | CYTK | ▼ | $117K |
| 2025-05-14 | CYTK | A | $0 |
| 2025-05-14 | CYTK | A | $0 |
Other Insiders at CYTK (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HENDERSON JOHN T | — | — | 2026-04-15 |
| WIERENGA WENDELL | — | — | 2026-04-15 |
|
Blum Robert I
President & CEO
|
— | $990K | 2026-04-15 |
| Wysenski Nancy | — | — | 2026-04-15 |
|
Malik Fady Ibraham
EVP Research & Development
|
— | $523K | 2026-04-21 |
| Daly James M | — | — | 2026-04-15 |
|
Callos Andrew
EVP, Chief Commercial Officer
|
— | $728K | 2026-04-15 |
| Harrington Robert Arthur | — | — | 2026-04-15 |